[go: up one dir, main page]

HK1246161A1 - Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine - Google Patents

Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine Download PDF

Info

Publication number
HK1246161A1
HK1246161A1 HK18105615.4A HK18105615A HK1246161A1 HK 1246161 A1 HK1246161 A1 HK 1246161A1 HK 18105615 A HK18105615 A HK 18105615A HK 1246161 A1 HK1246161 A1 HK 1246161A1
Authority
HK
Hong Kong
Prior art keywords
fmdv
mva
vaccine
foot
mouth disease
Prior art date
Application number
HK18105615.4A
Other languages
Chinese (zh)
Inventor
Robin Steigerwald
Markus Kalla
Original Assignee
Bavarian Nordic A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic A/S filed Critical Bavarian Nordic A/S
Publication of HK1246161A1 publication Critical patent/HK1246161A1/en

Links

HK18105615.4A 2015-06-15 2016-06-15 Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine HK1246161A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/175,738 2015-06-15

Publications (1)

Publication Number Publication Date
HK1246161A1 true HK1246161A1 (en) 2018-09-07

Family

ID=

Similar Documents

Publication Publication Date Title
IL290052A (en) Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
HUE059343T2 (en) Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
ZA201904717B (en) Therapeutic hpv18 vaccines
MA52645A (en) RESPIRATORY VIRUS VACCINES
ZA201701851B (en) Fmdv recombinant vaccines and uses thereof
EP3364981A4 (en) VACCINE AGAINST THE CYTOMEGALOVIRUS HUMAN
EP3261669A4 (en) Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
SG11201900439XA (en) Recombinant vaccinia virus and use thereof
EP2432503A4 (en) Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva)
EP3127552A4 (en) Microneedle array preparation comprising inactivated whole virus vaccine and method for administering same
MA53543A (en) PEPTIDE VACCINES
DK3244920T5 (en) Foot and mouth disease vaccine
EP3212672A4 (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
EP3365005C0 (en) RECOMBINANT MOPEIA VIRUS AND VACCINE PLATFORM
IL254698A0 (en) Recombinant mumps virus jeryl lynn 2 based vaccine
WO2014140166A3 (en) Vaccine
IL258056A (en) Foxm1-derived peptide, and vaccine including same
EP3515929A4 (en) THERAPEUTIC VACCINES AGAINST HEPATITIS B VIRUS
MA45994A (en) VACCINES AGAINST VIRUSES
SG11201808268UA (en) Recombinant hansenula-based high dosage hepatitis b vaccine
IL254970A0 (en) Recombinant nodular skin disease virus mutant and uses thereof
HK1246161A1 (en) Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine
PT3407910T (en) Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
HK1234648A1 (en) Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
EP3211073A4 (en) Replicative vaccinia virus vector hiv vaccine